(Q43637996)

English

Low-dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low-density lipoprotein cholesterol in patients with primary hypercholesterolemia

scientific article published in June 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 November 2017

Low-dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low-density lipoprotein cholesterol in patients with primary hypercholesterolemia (English)

1 reference

Europe PubMed Central

25 November 2017

hypercholesterolemia

0 references

1 reference

based on heuristic

inferred from title

author name string

M H Davidson

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655189&resulttype=core&format=json

15 May 2020

P Toth

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655189&resulttype=core&format=json

15 May 2020

S Weiss

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655189&resulttype=core&format=json

15 May 2020

J McKenney

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655189&resulttype=core&format=json

15 May 2020

D Hunninghake

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655189&resulttype=core&format=json

15 May 2020

J Isaacsohn

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655189&resulttype=core&format=json

15 May 2020

J M Donovan

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655189&resulttype=core&format=json

15 May 2020

S K Burke

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655189&resulttype=core&format=json

15 May 2020

publication date

1 June 2001

1 reference

Europe PubMed Central

25 November 2017

Clinical Cardiology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655189&resulttype=core&format=json

15 May 2020

24

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655189&resulttype=core&format=json

15 May 2020

467-474

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655189&resulttype=core&format=json

15 May 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655189&resulttype=core&format=json

15 May 2020

Primary prevention of coronary heart disease: integrating risk assessment with intervention

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960240610

21 January 2018

Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960240610

21 January 2018

Dose-response characteristics of cholesterol-lowering drug therapies: implications for treatment

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960240610

21 January 2018

Role of the enterohepatic circulation of bile salts in lipoprotein metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/11403509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors. NHLBI post coronary artery bypass graft clinical trial. Post CABG Trial Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/11403509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug treatment of lipid disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/11403509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Colesevelam hydrochloride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/11403509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug interactions with colesevelam hydrochloride, a novel, potent lipid-lowering agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/11403509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bile acid sequestrants: mechanisms of action on bile acid and cholesterol metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/11403509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and pharmacodynamics of pravastatin alone and with cholestyramine in hypercholesterolemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/11403509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

https://pubmed.ncbi.nlm.nih.gov/11403509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11403509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program. An approach to accurate and precise lipid measurements

1 reference

https://pubmed.ncbi.nlm.nih.gov/11403509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts

1 reference

https://pubmed.ncbi.nlm.nih.gov/11403509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits

1 reference

https://pubmed.ncbi.nlm.nih.gov/11403509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of primary moderate hypercholesterolemia with lovastatin (mevinolin) and colestipol

1 reference

https://pubmed.ncbi.nlm.nih.gov/11403509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11403509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/11403509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11403509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings?

1 reference

https://pubmed.ncbi.nlm.nih.gov/11403509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholesterol-lowering diets. A review of the evidence

1 reference

https://pubmed.ncbi.nlm.nih.gov/11403509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://pubmed.ncbi.nlm.nih.gov/11403509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

1 reference

https://pubmed.ncbi.nlm.nih.gov/11403509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

1 reference

https://pubmed.ncbi.nlm.nih.gov/11403509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug therapy for hypercholesterolemia in patients with cardiovascular disease: factors limiting achievement of lipid goals

1 reference

https://pubmed.ncbi.nlm.nih.gov/11403509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/11403509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The rule of 5 and the rule of 7 in lipid-lowering by statin drugs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11403509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of cholestyramine on the pharmacokinetics of cerivastatin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11403509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Persistence of use of lipid-lowering medications: a cross-national study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11403509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11403509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective evaluation of a stiff shaft glide wire compared with the standard straight wire in crossing severely stenotic aortic valves

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960240610

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CLC.4960240610

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655189&resulttype=core&format=json

15 May 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655189&resulttype=core&format=json

15 May 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655189&resulttype=core&format=json

15 May 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43637996&oldid=2102032226"